Oxalo Therapeutics is developing first-in-class therapeutics to treat rare renal diseases and prevent recurrent kidney stones. Primary hyperoxaluria is a monogenic autosomal recessive …

Oxaloacetic acid (also known as oxalacetic acid or OAA) is a crystalline organic compound with the chemical formula HO 2 CC (O)CH 2 CO 2 H. Oxaloacetic acid, in the form of its conjugate …

Oxalo Therapeutics is a committed to developing first-in-class therapeutics to treat and prevent diseases caused by hyperoxaluria and hyperoxalemia. We are a preclinical stage …

At Oxalo, we are committed to developing innovative therapies for patients with severe and rare kidney diseases caused by oxalate.

2018年9月29日 · Oxalo Therapeutics, a University of Chicago biotech startup, was awarded a $2.3 million grant to develop a first-of-its-kind drug to prevent kidney stones

2018年9月25日 · Named after Oxalobacter formigenes, a gut bacteria linked to reduced risks of kidney stones, the company will receive the $2.3 million grant in two parts—one this month …

Oxalo Capsule is used for promoting kidney health. It is formulated with a potent blend of probiotics, including Oxalobacter formigenes, Lactobacillus acidophilus, Bifidobacterium lactis …

2023年3月13日 · Oxalo Forte Capsule is a special probiotic combination used in the management of hyperoxaluria (too much oxalate in urine). It contains Oxalobacter formigenes, …